FDA rejects Aldeyra dry eye disease drug for 3rd time, citing inconsistent study findings
FDA rejects Aldeyra dry eye disease drug for 3rd time, citing inconsistent study findings
Body unavailable. Use the original source.
FDA rejects Aldeyra dry eye disease drug for 3rd time, citing inconsistent study findings
A compact weekly email covering company moves, product signals, regulatory updates, and notable funding.